MEDTECH POLICY PERSPECTIVE

AdvaMed is a global trade association for the medical technology industry, advocating for policies that “foster the highest ethical standards, rapid product approvals, appropriate reimbursement, and access to international markets.” Articles in this series tackle the major government, regulatory, and economic issues affecting medical device manufacturers today, including the innovation ecosystem, new payment paradigms, and the medical device tax, among others.

ARTICLES IN THIS SERIES

CMS Should Follow FDA’s Lead: Adopt Reforms To Facilitate Medtech Innovation
The Centers for Medicare and Medicaid Services (CMS) should take a cue from FDA and implement impactful reforms and efficiencies that will help support investment, innovation, and timely patient access to the best in American medicine.   Continue Reading..
5 Keys To Revitalizing The Medtech Innovation Ecosystem
America’s medical technology industry creates life-saving and life-enhancing treatments and cures that drive efficiencies and cost savings in the health care system, improve the quality of patient care, and generate high-quality jobs that contribute to economic growth. But today, the innovation ecosystem that supports medical technology development is severely stressed. This article proposes a new framework to respond to these...  Continue Reading..
Supporting Medtech Innovation Requires Changes To New Payment Paradigms
The unintended consequences of accountable care organizations (ACOs) and bundled payment initiatives.  Continue Reading..
Medical Device Tax Is Cutting Jobs, R&D, And U.S. Investment
The medical device and diagnostics industry is an American success story, creating life-saving and life-enhancing innovations every day while providing high-quality jobs in communities both large and small. Unfortunately, the 2.3 percent medical device excise tax implemented in January 2013 threatens this success and has already had a negative impact on jobs, R&D, and investment. Policymakers need to act now to address this burdensome tax...  Continue Reading..
Q&A: Edwards Lifesciences VP Discusses Physician Payments Sunshine Act
Christopher White, general counsel for AdvaMed, recently sat down with Diane Biagianti,VP and chief responsibility officer for Edwards Lifesciences, to talk about the importance of collaboration between physicians and medical technology companies, and implementing the Physician Payments Sunshine Act. By Christopher White, general counsel, AdvaMed  Continue Reading..
Sunshine Act: Understanding Appropriate Industry-Physician Interactions
As the Centers for Medicare and Medicaid Services (CMS) works to develop a searchable public website for reported “transfers of value” from health industry manufacturers to physicians and teaching hospitals, as required under the Physician Payment Sunshine Act, the requirement for “background information on industry-physician relationships” deserves significant attention. By Christopher L. White, Senior Executive VP and...  Continue Reading..